06.10.2012 - The Obama administration's reluctance to push for 12 years of data protection on "biologic" medicines in free-trade talks is a growing concern for U.S. drug manufacturers who...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)